Moll, the founder of surgical robotics leader Intuitive Surgical, brings decades of experience to the board at SS Innovations. Labeled the “father of surgical robotics” by SS Innovations, he co-founded Intuitive in the 1990s and oversaw its development and commercialization of the leading da Vinci system.
Most recently, Moll served as chief development officer for Johnson & Johnson Medical Devices from April 2019 to March 2023. He was a co-founder, chair and CEO of Auris Health, a robotics company acquired by J&J in 2019. Moll is also a current investor in SS Innovations.
“The strength and caliber of Dr. Moll’s leadership is peerless, and he will be a tremendous addition to our Board of Directors,” said Dr. Sudhir Srivastava, SS Innovations chair and CEO. “Joining us during the most robust phase of global growth to date, his appointment is perfectly timed. As a pioneer in robotic surgery, Dr. Moll offers a unique perspective and legacy as well as superior insight on the direction and promising future of the industry and SS Innovations.”
SS Innovations develops the Mantra platform of surgical robots, with the latest version coming in the form of its Mantra 3. The company launched Mantra 3 earlier this year and initiated the regulatory process in the U.S. and Europe. It hopes for approvals in the latter half of 2024 or 2025.
Mantra 3 provides capabilities for multi-specialty usage, including in cardiothoracic, head and neck, gynecology, urology, general surgery.
“I am excited to help with SS Innovation’s mission to bring the benefits of robotic surgery not just to more people in the United States but also to the rest of the world,” Moll said. “This technology should be available to everyone on the planet, and I believe the company successfully addresses the reasons why others have not yet been able to do so. It is much more affordable than what is out there now without sacrificing any clinical capabilities. It even has capabilities such as in cardiac that no one else even has. I also believe that the system’s proven telesurgery capabilities as well as its related teaching and proctoring tools will prove invaluable.”
